A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer

por Kelly, R J, Shepherd, F A, Krivoshik, A, Jie, F, Horn, L
Publicado 2019

VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.

por Evans, W. K., Eisenhauer, E., Hughes, P., Maroun, J. A., Ayoub, J., Shepherd, F. A., Feld, R.
Publicado 1988

Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer

por Zhu, C-Q, Cutz, J-C, Liu, N, Lau, D, Shepherd, F A, Squire, J A, Tsao, M-S
Publicado 2006

Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

por Shepherd, F. A., Johnston, M. R., Payne, D., Burkes, R., Deslauriers, J., Cormier, Y., de Bedoya, L. D., Ottaway, J., James, K., Zee, B.
Publicado 1998

Malignant mesothelioma: Canadian perspective and research directions

por Lee, C.W., Martin, J., MacRae, R., Tsao, M.S., Nguyen, E., Johnston, M., Baas, P., Laurie, S., Feld, R., Murray, N., Shepherd, F.A.
Publicado 2008

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national conse...

por Ellis, P.M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F.A., Soulieres, D., Tsao, M.S., Goss, G.
Publicado 2009

Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma

por Früh, M, Zhou, W, Zhai, R, Su, L, Heist, R S, Wain, J C, Nishioka, N S, Lynch, T J, Shepherd, F A, Christiani, D C, Liu, G
Publicado 2008

Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer

por Leighl, N B, Shepherd, F A, Zawisza, D, Burkes, R L, Feld, R, Waldron, J, Sun, A, Payne, D, Bezjak, A, Tattersall, M H N
Publicado 2008

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

por Diaz-Padilla, I, Siu, L L, San Pedro-Salcedo, M, Razak, A R A, Colevas, A D, Shepherd, F A, Leighl, N B, Neal, J W, Thibault, A, Liu, L, Lisano, J, Gao, B, Lawson, E B, Wakelee, H A
Publicado 2012